Business Segments · Net sales of reportable segments
MedSurg — Net sales of reportable segments
Boston Scientific MedSurg — Net sales of reportable segments increased by 5.2% to $1.80B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.2%, from $1.62B to $1.80B. Over 4 years (FY 2021 to FY 2025), MedSurg — Net sales of reportable segments shows an upward trend with a 10.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2020
Last reportedQ4 2025
How to read this metric
Growth indicates successful product adoption and market share expansion within the segment's therapeutic areas.
Detailed definition
The total revenue generated by the MedSurg segment from the sale of medical devices and related services to external cus...
Peer comparison
Standard top-line revenue metric used across all public medical device companies.
Metric ID:
bsx_segment_medsurg_net_sales_of_reportable_segmentsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.19B | $1.14B | $1.25B | $1.16B | $1.28B | $1.26B | $1.36B | $1.25B | $1.33B | $1.32B | $1.42B | $1.40B | $1.48B | $1.47B | $1.62B | $1.60B | $1.71B | $1.71B | $1.80B |
| QoQ Change | — | -4.2% | +10.0% | -6.7% | +9.8% | -1.4% | +7.5% | -7.6% | +6.3% | -1.0% | +7.7% | -1.2% | +5.6% | -0.7% | +10.3% | -1.4% | +7.3% | +0.0% | +5.2% |
| YoY Change | — | — | — | — | +7.8% | +11.0% | +8.6% | +7.6% | +4.1% | +4.6% | +4.7% | +12.0% | +11.2% | +11.5% | +14.2% | +14.0% | +15.8% | +16.6% | +11.2% |
Range$1.14B – $1.80B
CAGR+9.8%
Avg YoY Growth+10.3%
Median YoY Growth+11.2%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's medsurg — net sales of reportable segments?
- Boston Scientific (BSX) reported medsurg — net sales of reportable segments of $1.80B in Q4 2025.
- How has Boston Scientific's medsurg — net sales of reportable segments changed year-over-year?
- Boston Scientific's medsurg — net sales of reportable segments increased by 11.2% year-over-year, from $1.62B to $1.80B.
- What is the long-term trend for Boston Scientific's medsurg — net sales of reportable segments?
- Over 4 years (2021 to 2025), Boston Scientific's medsurg — net sales of reportable segments has grown at a 10.3% compound annual growth rate (CAGR), from $4.62B to $6.83B.
- What does medsurg — net sales of reportable segments mean?
- Total revenue earned by the MedSurg business unit from external customers.